lexiara

preamble_15

Whereas the Community must be provided with the means to undertake a scientific evaluation of medicinal products which are presented for authorization in accordance with the centralized Community procedures; whereas, furthermore, in order to achieve the effective harmonization of the administrative decisions taken by Member States in relation to individual medicinal products which are presented for authorization in accordance with decentralized procedures, it is necessary to provide the Community with the means of resolving disagreements between Member States about the quality, safety and efficacy of medicinal products;

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.